Global Viscosupplementation Injection Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Global Viscosupplementation Injection Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Viscosupplementation Injection market size was valued at US$ 1246 million in 2024 and is forecast to a readjusted size of USD 1813 million by 2031 with a CAGR of 5.6% during review period.

Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis. Viscosupplementation can significantly reduce pain while improving the mobility and function of the joint to make activities of daily living and even athletic or strenuous exercise less painful. Viscosupplementation is a procedure that involves injecting hyaluronic acid, a gel-like fluid, directly into the joint. Hyaluronic acid is found naturally in the synovial fluid surrounding the joints to reduce friction during movement. The injection goes into effect by lubricating the joint and assisting the synovial fluid to create more cushion. This works to reduce pain and improve the range of motion or the mobility of the joint.

The viscosupplementation injection market is driven by the rising prevalence of osteoarthritis, particularly among the aging population. As this treatment involves injecting hyaluronic acid into the joints to improve mobility and reduce pain, it offers a non-surgical alternative to managing osteoarthritis symptoms. The growing demand for minimally invasive procedures and the increasing awareness of joint health are also propelling the market forward. Additionally, advancements in injection technology and the development of next-generation viscosupplements are enhancing treatment outcomes, further supporting market growth.

However, the market faces challenges, including the high cost of viscosupplementation procedures, which can limit patient access, especially in developing regions. Moreover, the treatment's effectiveness may vary between patients, with some experiencing limited relief, which can reduce overall patient satisfaction. Competition from alternative treatments, such as corticosteroid injections and joint replacement surgeries, also presents a challenge to the market's expansion. Regulatory hurdles and reimbursement issues may further impact market growth, as insurers may not fully cover these treatments.

North America is the largest consumption place, with a consumption market share nearly 51% in 2023. Following North America, Asia-Pacific is the second largest consumption place with the consumption market share of 26%. Market competition is intense. Sanofi, Bioventus, Seikagaku, Anika Therapeutics, LG Chem, Ferring, etc. are the leaders of the industry. Top six company with about 43% market share.

This report is a detailed and comprehensive analysis for global Viscosupplementation Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Viscosupplementation Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Viscosupplementation Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Viscosupplementation Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Viscosupplementation Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Viscosupplementation Injection

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Viscosupplementation Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Anika Therapeutics, Seikagaku, Zimmer Biomet, Bioventus, Ferring, LG Chem, Freda, Haohai Biological, Shanghai Jingfeng, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Viscosupplementation Injection market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Single Injection
Three Injection
Five Injection

Market segment by Application
Hospitals
Clinics
Others

Major players covered
Sanofi
Anika Therapeutics
Seikagaku
Zimmer Biomet
Bioventus
Ferring
LG Chem
Freda
Haohai Biological
Shanghai Jingfeng

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Viscosupplementation Injection product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Viscosupplementation Injection, with price, sales quantity, revenue, and global market share of Viscosupplementation Injection from 2020 to 2025.

Chapter 3, the Viscosupplementation Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Viscosupplementation Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Viscosupplementation Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Viscosupplementation Injection.

Chapter 14 and 15, to describe Viscosupplementation Injection sales channel, distributors, customers, research findings and conclusion.